Literature DB >> 17162528

Mortality and pathological findings in C (Opitz trigonocephaly) syndrome.

John M Opitz1, Angelica R Putnam, Jessica M Comstock, Steven Chin, Janice L B Byrne, Anne Kennedy, Maureen J Frikke, Chantal Bernard, Steffen Albrecht, Vazken Der Kaloustian, Juliana G Szakacs.   

Abstract

Even as a rare multiple congenital anomalies/mental retardation syndrome, the C-syndrome (CS, or Opitz C-trigonoecephaly syndrome) is, at long last, beginning to attract attention because of its developmental and causal complexity. Also, the possibility that the apparently balanced translocation recently described in an affected Japanese boy may soon provide a molecular/causal insight into this disorder. The manifestations recorded in the previously published patients, those autopsied within recent years, and the unpublished instances in our files suggest that the CS is a heterogeneous genetic disorder, predominantly sporadic but with sufficient familial cases (at times with consanguinity) to allow postulation of an entity due to autosomal dominant mutations with a high rate of germinal mosaicism, or due to both autosomal dominant mutations and an autosomal recessive genocopy. In any event, elucidation of cause and pathogenesis of CS will, in due time, shed light on its developmental pleiotropy, rarity in liveborn infants, prevalence in stillborn fetuses, recurrence risk in humans, and occurrence in other animals (e.g., mice) to further understanding of pathogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 17162528     DOI: 10.1080/15513810601015753

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  5 in total

Review 1.  Pathology in metopic synostosis.

Authors:  Pinar Karabagli
Journal:  Childs Nerv Syst       Date:  2013-10-03       Impact factor: 1.475

2.  Mutations in CD96, a member of the immunoglobulin superfamily, cause a form of the C (Opitz trigonocephaly) syndrome.

Authors:  Tadashi Kaname; Kumiko Yanagi; Yasutsugu Chinen; Yoshio Makita; Nobuhiko Okamoto; Hiroki Maehara; Ichiro Owan; Fuminori Kanaya; Yoshiaki Kubota; Yuichi Oike; Toshiyuki Yamamoto; Kenji Kurosawa; Yoshimitsu Fukushima; Axel Bohring; John M Opitz; Ko-Ichiro Yoshiura; Norio Niikawa; Kenji Naritomi
Journal:  Am J Hum Genet       Date:  2007-08-27       Impact factor: 11.025

3.  Opitz trigonocephaly syndrome presenting with sudden unexplained death in the operating room: a case report.

Authors:  Laura Travan; Vanna Pecile; Mariacristina Fertz; Antonella Fabretto; Pierpaolo Brovedani; Sergio Demarini; John M Opitz
Journal:  J Med Case Rep       Date:  2011-06-21

4.  A De Novo FOXP1 Truncating Mutation in a Patient Originally Diagnosed as C Syndrome.

Authors:  Roser Urreizti; Sarah Damanti; Carla Esteve; Héctor Franco-Valls; Laura Castilla-Vallmanya; Raul Tonda; Bru Cormand; Lluïsa Vilageliu; John M Opitz; Giovanni Neri; Daniel Grinberg; Susana Balcells
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

5.  A De Novo Nonsense Mutation in MAGEL2 in a Patient Initially Diagnosed as Opitz-C: Similarities Between Schaaf-Yang and Opitz-C Syndromes.

Authors:  Roser Urreizti; Anna Maria Cueto-Gonzalez; Héctor Franco-Valls; Sílvia Mort-Farre; Neus Roca-Ayats; Julia Ponomarenko; Luca Cozzuto; Carlos Company; Mattia Bosio; Stephan Ossowski; Magda Montfort; Jochen Hecht; Eduardo F Tizzano; Bru Cormand; Lluïsa Vilageliu; John M Opitz; Giovanni Neri; Daniel Grinberg; Susana Balcells
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.